Skip to main content
. Author manuscript; available in PMC: 2020 Jan 1.
Published in final edited form as: Am J Med. 2018 Sep 19;132(1):71–80.e1. doi: 10.1016/j.amjmed.2018.09.011

Figure 2.

Figure 2.

Love plot displaying absolute standardized differences for 58 baseline characteristics between patients receiving and not receiving a discharge prescription for spironolactone, before and after propensity score matching. Data based on patients with heart failure, left ventricular ejection fraction ≤35%, no prior spironolactone therapy, and serum creatinine ≤2.5mg/dL for men and ≤2.0mg/dL for women. A standardized difference of 0% indicates no residual bias and values <10% indicate inconsequential bias (ACE=angiotensin-converting enzyme; ARB=angiotensin receptor blockers; BP=blood pressure; CCB= calcium channel blocker; COPD=chronic obstructive pulmonary disease)